Homestead Advisers Corp Emergent Bio Solutions Inc. Transaction History

Homestead Advisers Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$50.07 - $66.05 $80,112 - $105,680	1,600 Added 2.86%	57,525 $2.88 Million
Q1 2021 May 07, 2021	SELL	$86.23 - $125.19 $232,821 - $338,013	-2,700 Reduced 4.61%	55,925 $5.2 Million
Q4 2020 Feb 10, 2021	SELL	$79.17 - $111.47 $356,265 - $501,615	-4,500 Reduced 7.13%	58,625 $5.25 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $532,415 - $877,110	-6,500 Reduced 9.34%	63,125 $6.52 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $38,031 - $62,664	-700 Reduced 1.0%	69,625 $5.51 Million
Q1 2020 May 14, 2020	SELL	$49.34 - $68.76 $84,864 - $118,267	-1,720 Reduced 2.39%	70,325 $4.07 Million
Q4 2019 Feb 13, 2020	SELL	$51.21 - $59.06 $3.29 Million - $3.8 Million	-64,299 Reduced 47.16%	72,045 $3.89 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $659,100 - $928,584	16,234 Added 13.52%	136,344 $7.13 Million
Q2 2019 Aug 12, 2019	BUY	$39.92 - $53.86 $186,665 - $251,849	4,676 Added 4.05%	120,110 $5.8 Million
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $5.57 Million - $7.64 Million	115,434 New	115,434 $5.83 Million

173

36.7M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $232M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

Stay updated on Homestead Advisers Corp with notifications on news.